ArticlePharmacological research2020

Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study.

Jiaxing Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.